Covaxin's emergency use authorisation approval significant landmark in India's scientific discovery
Updated Jan 03, 2021 | 13:41 IST Covaxin is a highly purified and inactivated 2 dose SARS-CoV2 vaccine, manufactured in a Vero cell manufacturing platform with an excellent safety track record of more than 300 million doses. Representational Image  Hyderabad: Expressing delight on the Ministry of Health & Family Welfare announcement and the statement from DCGI - Central Standards Control Organization (CDSCO) Grant of permission for emergency use of its Covid-19 Vaccine today, the Chairman and Managing Director of Bharat Biotech Dr Krishna Ella said “The appr...